Catalyst Wire Dossier Catalyst Wire Dossier

Sixmo

buprenorphine hydrochloride · L. Molteni & C. dei Fratelli Alitti Società di Esercizio S.p.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sixmo, covering 2025-08-14 to 2025-08-14. Get the full timeline:

Most recent: EMA Withdrawn: Sixmo (buprenorphine hydrochloride) — L. Molteni & C. dei Fratelli Alitti Società di Esercizio S.p.A.

See pricing